Succinylcholine - Revision history

Huckfinne: add absolute contraindications

2022-07-17T23:41:21Z

add absolute contraindications

← Older revision		Revision as of 16:41, 17 July 2022
Line 31:		Line 31:

	===Absolute contraindications<!-- List absolute contraindications for use of the drug. If none, this section may be removed. -->===		===Absolute contraindications<!-- List absolute contraindications for use of the drug. If none, this section may be removed. -->===

			* hyperkalemia
			* increased risk of [[Malignant Hyperthermia\|malignant hyperthermia]]
			* open globe injury
			* allergy

	===Precautions<!-- List precautions for use of the drug. If none, this section may be removed. -->===		===Precautions<!-- List precautions for use of the drug. If none, this section may be removed. -->===

Chris.Rishel: Added embedded dosage calculation

2022-03-30T07:34:22Z

Added embedded dosage calculation

← Older revision		Revision as of 00:34, 30 March 2022
Line 1:		Line 1:
	{{Infobox drug reference		{{Infobox drug reference
	\| trade_names =Anectine		\| trade_names = Anectine
	\| drug_class =Depolarizing neuromuscular blocker		\| drug_class = Depolarizing neuromuscular blocker
	\| drug_class_color =succinylcholine		\| drug_class_color = succinylcholine
	\| uses =Paralysis for intubation		\| uses = Paralysis for intubation
	\| contraindications =History/risk of [[Malignant hyperthermia\|malignant hyperthermia]]<br />		\| contraindications = History/risk of [[Malignant hyperthermia\|malignant hyperthermia]]<br />
	Conditions which proliferate extrajunctional acetylcholine receptors		Conditions which proliferate extrajunctional acetylcholine receptors
	\| routes =Intravenous, intramuscular		\| routes = Intravenous, intramuscular
	\| dosage =~~0.5-1.5 mg/kg~~		\| dosage =
	\|halflife_elimination=\|image_file=Succinylcholine.svg\|protein_binding=\|clearance=\|time_onset=30-60 seconds (IV)<br />		\| halflife_elimination =
	2-3 minutes (IM)\|halflife_redistribution=\|metabolism=Plasma cholinesterase\|duration=5-10 minutes (IV)<br />		\| image_file = Succinylcholine.svg
	10-30 minutes (IM)\|adverse_effects=Bradycardia, hyperkalemia, malignant hyperthermia, myalgias\|mechanism=Depolarizing blockade of neuromuscular junction\|formula=}}		\| protein_binding =
			\| clearance =
			\| time_onset = 30-60 seconds (IV)<br />
			2-3 minutes (IM)
			\| halflife_redistribution =
			\| metabolism = Plasma cholinesterase
			\| duration = 5-10 minutes (IV)<br />
			10-30 minutes (IM)
			\| adverse_effects = Bradycardia, hyperkalemia, malignant hyperthermia, myalgias
			\| dosage_calculation = succinylcholine
			\| mechanism = Depolarizing blockade of neuromuscular junction
			\| formula =
			}}

	'''Succinylcholine''', also known as '''suxamethonium''', is a short-acting neuromuscular blocker used during intubation.		'''Succinylcholine''', also known as '''suxamethonium''', is a short-acting neuromuscular blocker used during intubation.

Chris.Rishel at 17:21, 18 February 2021

2021-02-18T17:21:15Z

← Older revision		Revision as of 10:21, 18 February 2021
Line 37:		Line 37:

	==References==		==References==
			[[Category:Drug reference]]
			[[Category:Neuromuscular blockers]]

Chris.Rishel: Created page with "{{Infobox drug reference | trade_names =Anectine | drug_class =Depolarizing neuromuscular blocker | drug_class_color =succinylcholine | uses =Paralysis for intubation | co..."

2021-02-18T17:04:49Z

Created page with "{{Infobox drug reference | trade_names =Anectine | drug_class =Depolarizing neuromuscular blocker | drug_class_color =succinylcholine | uses =Paralysis for intubation | co..."

New page

{{Infobox drug reference
| trade_names =Anectine
| drug_class =Depolarizing neuromuscular blocker
| drug_class_color =succinylcholine
| uses =Paralysis for intubation
| contraindications =History/risk of [[Malignant hyperthermia|malignant hyperthermia]]<br />
Conditions which proliferate extrajunctional acetylcholine receptors
| routes =Intravenous, intramuscular
| dosage =0.5-1.5 mg/kg
|halflife_elimination=|image_file=Succinylcholine.svg|protein_binding=|clearance=|time_onset=30-60 seconds (IV)<br />
2-3 minutes (IM)|halflife_redistribution=|metabolism=Plasma cholinesterase|duration=5-10 minutes (IV)<br />
10-30 minutes (IM)|adverse_effects=Bradycardia, hyperkalemia, malignant hyperthermia, myalgias|mechanism=Depolarizing blockade of neuromuscular junction|formula=}}

'''Succinylcholine''', also known as '''suxamethonium''', is a short-acting neuromuscular blocker used during intubation.

==Uses==

==Contraindications==

===Absolute contraindications===

===Precautions===

==Pharmacology==

===Pharmacodynamics===

====Mechanism of action====

====Adverse effects====

===Pharmacokinetics===

==Chemistry and formulation==

==History==

==References==